POST Online Media Lite Edition


Transcenta appoints Daniel Weng as CFO

Christian Fernsby |
Suzhou, China - Transcenta, a clinical stage biopharmaceutical company, announced the appointment of Daniel Weng as the company'srnCFO.

Article continues below

rior to joining Transcenta, Mr. Weng served as the vice president and Head of finance at CStone Pharmaceuticals.

Prior to CStone Pharmaceuticals, Mr. Weng served as the vice president and head of finance at Everest Medicines.

Prior to that, he served as the CFO of China at Amgen.

Before Amgen, Mr. Weng was serving as the senior and executive finance professional at multinational companies like GE, Honeywell in China and overseas.

Mr. Weng holds a master's degree from University of Sydney in Finance and Accounting in Australia.


ARC Automotive appoints Alex Qin as acting president and CEO
JinkoSolar appoints Hao Jin as chief technology officer
CARsgen Therapeutics appoints Yong Fan as senior vice president
Hang Seng Bank appoints Joe Lam as CEO of Hang Seng Insurance
China Reinsurance appoints Xiaopeng Liu as non-executive director